In response to the expanding global threat, Medocity accelerated development of a targeted digital program with COVID-19 specific clinical protocols to:

  • Aid in the early identification of possible COVID-19 cases in a population
  • Proactively push frequent, consistent, relevant communications and guidance personalized to each user
  • Allow for real-time active monitoring of individuals and reported symptoms
  • Facilitate timely escalation of care as changes in health status are noted
  • Track and report evolving COVID-19 related population health statistics and trends over time to ensure resources are appropriately deployed

“The Medocity platform’s data and reporting capability allow for a systematic view of users’ COVID-19 symptoms and status in real-time and by location. There have been examples from around the globe where this type of systematic monitoring and targeted response is proving to be a key component in the fight to stop the spread of the disease,” said Robert Epstein, MD, epidemiologist, CEO of Epstein Health and member of Medocity’s Medical Advisory Board. “As hospitals and doctors-offices become inaccessible, we now see that we have to move away from reliance on in-person patient visits and use digital solutions to shift to remote, cost-effective, large-scale population surveillance and targeted intervention that would otherwise be impossible to do.”

Hillcrest Home Care clinical team members will use their own mobile devices to provide daily self-reported symptom checks to ensure they are healthy and able to report to work. Separately, low-risk at-home patients can use their own mobile devices to perform the same self-assessments. For high-risk COPD and CHF patients, Hillcrest will utilize its existing remote monitoring program with pre-configured tablets and devices supplied by Medocity. Any reported patient-vitals such as temperature, heart rate, or oxygen levels (pulse ox) that are outside pre-determined parameters will trigger real-time clinician alerts and appropriate, proactive COVID-19 interventions.

“Our remote patient monitoring capabilities can be used for chronic and complex condition management, including co-morbidities, or for crisis management as we are demonstrating with our COVID-19 digital solution,” said Raj Agarwal, President, and CEO of Medocity. “Backed by recent FDA encouragement, Hillcrest Home Care providers now have visibility to patient’s at-home health status which may reduce the need for in-person visits and decrease the risk of coronavirus exposure. During this uncertain time, Medocity’s highly configurable, cloud-based digital platform allows any sponsor – including health care providers, payers, clinical researchers or public health agencies – to easily and quickly go virtual.”

For more information, please visit